Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $458.34 | 4 | 88.4% |
| Education | $60.00 | 2 | 11.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $355.29 | 3 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $103.05 | 1 | $0 (2019) |
| AtriCure, Inc. | $60.00 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $341.34 | 3 | AstraZeneca Pharmaceuticals LP ($238.29) |
| 2018 | $117.00 | 1 | AstraZeneca Pharmaceuticals LP ($117.00) |
| 2017 | $60.00 | 2 | AtriCure, Inc. ($60.00) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/14/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $118.66 | General |
| Category: Oncology | ||||||
| 02/20/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $119.63 | General |
| Category: Oncology | ||||||
| 01/15/2019 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological) | Food and Beverage | In-kind items and services | $103.05 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2018 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $117.00 | General |
| Category: Oncology | ||||||
| 10/03/2017 | AtriCure, Inc. | ATRICURE ATRICLIP LAA EXCLUSION SYSTEM (Device) | Education | Cash or cash equivalent | $30.00 | General |
| Category: CARDIOTHORACIC | ||||||
| 09/30/2017 | AtriCure, Inc. | ATRICURE ATRICLIP LAA EXCLUSION SYSTEM (Device) | Education | Cash or cash equivalent | $30.00 | General |
| Category: CARDIOTHORACIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,862 | 9,583 | $1.3M | $435,619 |
| 2022 | 18 | 2,756 | 9,299 | $1.2M | $389,445 |
| 2021 | 18 | 3,055 | 10,898 | $1.3M | $459,037 |
| 2020 | 24 | 2,113 | 6,031 | $687,397 | $256,428 |
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88374 | Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | Office | 2023 | 148 | 600 | $308,754 | $139,285 | 45.1% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 197 | 4,519 | $397,550 | $80,472 | 20.2% |
| 88360 | Microscopic genetic analysis of tumor, manual | Office | 2023 | 127 | 506 | $103,263 | $43,836 | 42.5% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 172 | 399 | $44,648 | $24,915 | 55.8% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 86 | 637 | $57,375 | $20,047 | 34.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 189 | 361 | $47,954 | $19,826 | 41.3% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2023 | 244 | 273 | $47,858 | $17,196 | 35.9% |
| 88374 | Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | Facility | 2023 | 107 | 440 | $32,797 | $14,319 | 43.7% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Office | 2023 | 201 | 206 | $36,143 | $13,264 | 36.7% |
| 88184 | Flow cytometry technique for dna or cell analysis, first marker | Office | 2023 | 199 | 203 | $29,194 | $11,518 | 39.5% |
| 85097 | Bone marrow, smear interpretation | Facility | 2023 | 233 | 237 | $33,220 | $8,644 | 26.0% |
| 88367 | Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure | Office | 2023 | 85 | 87 | $36,381 | $7,542 | 20.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 127 | 224 | $13,494 | $6,320 | 46.8% |
| 88365 | Genetic sequencing localization, initial procedure | Office | 2023 | 41 | 41 | $11,687 | $5,570 | 47.7% |
| 88373 | Microscopic genetic analysis of tissue, computer-assisted technology, each additional procedure | Office | 2023 | 86 | 88 | $13,196 | $4,609 | 34.9% |
| 88364 | Genetic sequencing localization, each additional procedure | Office | 2023 | 37 | 39 | $8,235 | $4,007 | 48.7% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Office | 2023 | 167 | 169 | $5,877 | $2,667 | 45.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 19 | 67 | $6,624 | $1,440 | 21.7% |
| 88365 | Genetic sequencing localization, initial procedure | Facility | 2023 | 38 | 41 | $3,913 | $1,346 | 34.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 71 | 145 | $2,832 | $1,329 | 46.9% |
| 88367 | Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure | Facility | 2023 | 44 | 47 | $4,622 | $1,199 | 25.9% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 14 | 14 | $2,622 | $1,076 | 41.0% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2023 | 16 | 16 | $5,413 | $929.92 | 17.2% |
| 88373 | Microscopic genetic analysis of tissue, computer-assisted technology, each additional procedure | Facility | 2023 | 44 | 47 | $2,256 | $904.73 | 40.1% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 13 | 15 | $2,015 | $876.27 | 43.5% |
About Yuan Lin, MD PHD
Yuan Lin, MD PHD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Gilbert, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942280367.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Yuan Lin, MD PHD has received a total of $518.34 in payments from pharmaceutical and medical device companies, with $341.34 received in 2019. These payments were reported across 6 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($458.34).
As a Medicare-enrolled provider, Lin has provided services to 10,786 Medicare beneficiaries, totaling 35,811 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Gilbert, AZ
- Active Since 01/20/2006
- Last Updated 08/05/2020
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1942280367
Products in Payments
- LYNPARZA (Drug) $238.29
- TAGRISSO (Drug) $117.00
- KYMRIAH (Biological) $103.05
- ATRICURE ATRICLIP LAA EXCLUSION SYSTEM (Device) $60.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Gilbert
Dr. Antonio Torloni, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $585.80
Dr. Stefan Costinean, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $119.63
Dr. George Corcoran, Md, MD
Anatomic Pathology & Clinical Pathology
Dr. Michael Lewis, Md, MD
Anatomic Pathology & Clinical Pathology